Molecular Docking study, and In vitro Evaluation of Antitumor Activity of Some New Isoxazoline and Pyrazoline Derivatives of Nabumetone against breast cancer cell line (MCF-7). AJPS [Internet]. 2022 Oct. 24 [cited 2025 Apr. 25];22(3):24-3. Available from: https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/886